$opti Another vaccine went down...
— Phoenix (@lvald13) September 28, 2020
Inovio's shares halted, COVID-19 trial put on hold: https://t.co/U7J7a2uv64
$INO (-31.8% pre) Inovio's shares tumble 33% as COVID-19 vaccine trial is put on hold - MWhttps://t.co/NYvoNDyUX5
— Open Outcrier (@OpenOutcrier) September 28, 2020
Inovio has delayed the phase 2/3 trial of its DNA-based coronavirus vaccine after the FDA raised questions https://t.co/j1jJpxuUYD
— RR Seattle (@RRalstonAgile) September 28, 2020
Another setback for $INO's Covid-19 vaccine: A Phase 2/3 trial set to begin this month won't, because @US_FDA has more questions and put a clinical hold on the study, @JaredSHopkins reports https://t.co/iTBbQtmQvR. Inovio shares down ~28%.
— Jonathan Rockoff (@jonathanrockoff) September 28, 2020